Abstract

BackgroundMany microbes have evolved the ability to co-exist for long periods of time within other species in the absence of overt pathology. Evolutionary biologists have proposed benefits to the microbe from ‘asymptomatic persistent infections’, most commonly invoking increased likelihood of transmission by longer-lived hosts. Typically asymptomatic persistent infections arise from strong containment by the immune system, accompanied by protective immunity; such ‘vaccination’ from overt disease in the presence of a non-sterilizing immune response is termed premunition or concomitant immunity. Here we consider another potential benefit of persistence and concomitant immunity to the parasite: the ‘exclusion’ of competing super-infecting strains, which would favor transmission of the original infecting organism.Methodology / Principle FindingsTo investigate this in the protozoan parasite Leishmania major, a superb model for the study of asymptomatic persistence, we used isogenic lines of comparable virulence bearing independent selectable markers. One was then used to infect genetically resistant mice, yielding infections which healed and progressed to asymptomatic persistent infection; these mice were then super-infected with the second marked line. As anticipated, super-infection yielded minimal pathology, showing that protective immunity against disease pathology had been established. The relative abundance of the primary and super-infecting secondary parasites was then assessed by plating on selective media. The data show clearly that super-infecting parasites were able to colonize the immune host effectively, achieving numbers comparable to and sometimes greater than that of the primary parasite.Conclusions / SignificanceWe conclude that induction of protective immunity does not guarantee the Leishmania parasite exclusive occupation of the infected host. This finding has important consequences to the maintenance and generation of parasite diversity in the natural Leishmania infectious cycle alternating between mammalian and sand fly hosts.

Highlights

  • Persistent host/pathogen relationships are often characterized by a ‘stalemate’ in which the host neither succumbs to disease nor is able to completely achieve sterile cure

  • Several pathogen species have evolved the ability to persist indefinitely within their hosts despite the host’s acquisition of protective immunity against subsequent infection by that pathogen, a condition known as concomitant immunity

  • We asked whether ‘exclusivity’ was a force underlying the evolution of concomitant immunity using the protozoan parasite Leishmania major as a model

Read more

Summary

Introduction

Persistent host/pathogen relationships are often characterized by a ‘stalemate’ in which the host neither succumbs to disease nor is able to completely achieve sterile cure. In the case of concomitant immunity, the host benefits by its immune system’s ability to control the infection and minimize pathology, as well as protection from disease arising from new infections This comes at the cost of increased risk of disease reactivation, typically following immunosuppression or stress [1,4,13,14,15]. Asymptomatic persistent infections arise from strong containment by the immune system, accompanied by protective immunity; such ‘vaccination’ from overt disease in the presence of a non-sterilizing immune response is termed premunition or concomitant immunity. We consider another potential benefit of persistence and concomitant immunity to the parasite: the ‘exclusion’ of competing super-infecting strains, which would favor transmission of the original infecting organism

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call